# Selenium Supplementation of Patients With Cirrhosis

> **NCT00271245** · NA · TERMINATED · sponsor: **Vanderbilt University** · enrollment: 99 (actual)

## Conditions studied

- Liver Disease

## Interventions

- **DIETARY_SUPPLEMENT:** 200 µg selenium as selenate
- **DIETARY_SUPPLEMENT:** 400 µg selenium as selenate
- **DIETARY_SUPPLEMENT:** 200 µg selenium as selenomethionine
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT00271245
- **Lead sponsor:** Vanderbilt University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-02
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 99 (ACTUAL)
- **Why stopped:** Insufficient funds to complete study.
- **Last updated:** 2012-03-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00271245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00271245, "Selenium Supplementation of Patients With Cirrhosis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00271245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*